INDP Indaptus Therapeutics
- 2.180
- -0.170-7.23%
- 2.160
- -0.020-0.92%
Indaptus Therapeutics News
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Newman Michael James
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Meckler Jeffrey A
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sassi Nir
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Waltzman Roger J.
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Linscott Walt Addison
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Anderson Glen R.
Indaptus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Glen R. Anderson(14.17%)
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Waltzman Roger J.
Indaptus Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Waltzman Roger J.
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Karah Hila
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hayes William B
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gilbert Mark John
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pomerantz Roger
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MADDALUNA ANTHONY J
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Indaptus Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Martell Robert
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Indaptus Therapeutics | 4: Statement of changes in beneficial ownership of securities
Analysis
Price Target
No Data
